Skip to content

Structured preparation for alcohol detoxification

A feasibility study of an intervention for Structured Preparation before detoxification in Alcohol Dependence: the SPADe trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN14621127
Enrollment
50
Registered
2017-02-22
Start date
2017-10-01
Completion date
Unknown
Last updated
2021-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol misuse Mental and Behavioural Disorders Mental and behavioural disorders due to use of alcohol

Interventions

Once consented, participants will be randomised using a third-party web-based randomisation system which will ensure concealed allocation developed by UEA. Participants will be stratified according to
detoxification delivery
and aftercare. Clients enter detoxification at the first available opportunity (likely to be within 4 weeks from presentation). Whilst waiting for detoxification, they meet their key worker (one-to-on

Sponsors

Surrey and Borders Partnership NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Presentation to alcohol services seeking abstinence from alcohol 2. Alcohol dependence (moderate to severe), scoring 16 and above on Severity of Alcohol Dependence Questionnaire (SADQ) 3. Stated intention to stay in the area within the time period of the intervention 4. Willingness to be part of a group intervention if randomised to receive it 5. Aged 18 years and over

Exclusion criteria

Exclusion criteria: 1. Age less than 18 (as not usually treated by specialist alcohol services). 2. Pregnancy: Pregnant women need urgent intervention to come off alcohol, due to the effect of alcohol on the foetus. 3. Known terminal illness with life expectancy of less than 6 months. 4. Severe medical condition that requires urgent medical admission, which would lead to an un-planned medically assisted withdrawal. 5. Severe cognitive impairment that compromises capacity and /or ability to participate in a group intervention. 6. Acute stage of severe and enduring mental illness (schizophrenia, Bipolar Affective Disorder, recurrent depressive disorder: current episode severe), when acute symptomatology compromises client’s ability to participate in a group intervention.

Design outcomes

Primary

MeasureTime frame
1. Duration of continuous abstinence with no incidents of lapse or relapse is assessed by self-report with the use of Time Line Follow Back method at 3, 6 and 12 months post randomisation. 2. Percentage of Days of Abstinence (PDA) is assessed by self-report with the use of Time Line Follow Back method at 3, 6 and 12 months post randomisation 3. Time to relapse is assessed by self-report from randomisation to first day of alcohol use

Secondary

MeasureTime frame
1. Severity of alcohol dependence is measured using the Severity of Alcohol Dependence Questionnaire (SADQ) at baseline, 3, 6 and 12 months post randomisation 2. Severity of cravings and urges are measured using the Alcohol Urge Questionnaire at baseline, 3, 6 and 12 months post randomisation 3. Changes in cognitive performance is measured using the Incentive Conflict Task (ICT) at baseline, 3, 6 and 12 months post randomisation 4. Participation in aftercare is extracted from clinical notes retrospectively at 3,6 and 12 months post randomisation

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026